Few smokers develop COPD. Why? NM Siafakas, EG Tzortzaki Respiratory medicine 96 (8), 615-624, 2002 | 134 | 2002 |
Apoptotic mechanisms in the pathogenesis of COPD M Plataki, E Tzortzaki, P Rytila, M Demosthenes, A Koutsopoulos, ... International journal of chronic obstructive pulmonary disease 1 (2), 161-171, 2006 | 126 | 2006 |
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease NM Siafakas, KM Antoniou, EG Tzortzaki International journal of chronic obstructive pulmonary disease 2 (4), 453-462, 2007 | 117 | 2007 |
Microsatellite DNA instability in COPD NM Siafakas, EG Tzortzaki, G Sourvinos, D Bouros, N Tzanakis, A Kafatos, ... Chest 116 (1), 47-51, 1999 | 110 | 1999 |
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean “real-life” experience EG Tzortzaki, A Georgiou, D Kampas, M Lemessios, M Markatos, ... Pulmonary pharmacology & therapeutics 25 (1), 77-82, 2012 | 87 | 2012 |
A hypothesis for the initiation of COPD EG Tzortzaki, NM Siafakas European Respiratory Journal 34 (2), 310-315, 2009 | 84 | 2009 |
DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD) E Neofytou, EG Tzortzaki, A Chatziantoniou, NM Siafakas International journal of molecular sciences 13 (12), 16853-16864, 2012 | 83 | 2012 |
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases EG Tzortzaki, K Dimakou, E Neofytou, K Tsikritsaki, K Samara, M Avgousti, ... Chest 141 (5), 1243-1250, 2012 | 81 | 2012 |
Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients M Siganaki, AV Koutsopoulos, E Neofytou, E Vlachaki, M Psarrou, ... Respiratory research 11, 1-8, 2010 | 77 | 2010 |
Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri, A Koutsopoulos, ... Respiratory medicine 101 (8), 1821-1829, 2007 | 73 | 2007 |
Increased apoptosis of neutrophils in induced sputum of COPD patients D Makris, T Vrekoussis, M Izoldi, K Alexandra, D Katerina, T Dimitris, ... Respiratory medicine 103 (8), 1130-1135, 2009 | 71 | 2009 |
Decreased small airway and alveolar CD83+ dendritic cells in COPD M Tsoumakidou, AV Koutsopoulos, N Tzanakis, K Dambaki, E Tzortzaki, ... Chest 136 (3), 726-733, 2009 | 69 | 2009 |
Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management E Kostakou, E Kaniaris, E Filiou, I Vasileiadis, P Katsaounou, E Tzortzaki, ... Journal of clinical medicine 8 (9), 1283, 2019 | 58 | 2019 |
Expression of FACIT collagens XII and XIV during bleomycin‐induced pulmonary fibrosis in mice EG Tzortzaki, JA Tischfield, A Sahota, NM Siafakas, MK Gordon, ... The Anatomical Record Part A: Discoveries in Molecular, Cellular, and …, 2003 | 57 | 2003 |
Altered surfactant protein-A expression in type II pneumocytes in COPD EM Vlachaki, AV Koutsopoulos, N Tzanakis, E Neofytou, M Siganaki, ... Chest 137 (1), 37-45, 2010 | 53 | 2010 |
C‐reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy SE Schiza, C Mermigkis, P Panagiotis, I Bouloukaki, E Kallergis, ... European journal of clinical investigation 40 (11), 968-975, 2010 | 52 | 2010 |
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study M Kupczyk, S Haque, PJ Sterk, E Niżankowska-Mogilnicka, A Papi, ... Thorax 68 (7), 611-618, 2013 | 51 | 2013 |
Downregulation of lung mitochondrial prohibitin in COPD N Soulitzis, E Neofytou, M Psarrou, A Anagnostis, N Tavernarakis, ... Respiratory medicine 106 (7), 954-961, 2012 | 51 | 2012 |
Biomarkers in COPD EG Tzortzaki, I Lambiri, E Vlachaki, NM Siafakas Current medicinal chemistry 14 (9), 1037-1048, 2007 | 50 | 2007 |
Microsatellite DNA instability and loss of heterozygosity in bronchial asthma E Paraskakis, G Sourvinos, F Passam, N Tzanakis, EG Tzortzaki, ... European Respiratory Journal 22 (6), 951-955, 2003 | 50 | 2003 |